Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

This meta-analysis investigated the comparative efficacy and safety of PARP inhibitor monotherapy as maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC). Electronic databases were systematically searched for relevant RCTs. The primary endpoint was PFS. The results were stratif...

Full description

Bibliographic Details
Main Authors: Yangchun Xu, Lei Ding, Yuan Tian, Miaomiao Bi, Ning Han, Ling Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
PARP inhibitor
platinum
ovarian cancer
network meta-analysis
progress-free survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.573801/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.573801/full

Similar Items